Periodontitis affects glucoregulatory hormones in severely obese individuals
暂无分享,去创建一个
M. Seghieri | A. Solini | F. Graziani | S. Masi | S. Gennai | F. D’Aiuto | M. Petrini | J. Suvan | E. Santini
[1] A. Flyvbjerg,et al. Comorbidity of periodontal disease: two sides of the same coin? An introduction for the clinician , 2017, Journal of oral microbiology.
[2] T. Hirano,et al. Anti‐atherogenic and anti‐inflammatory properties of glucagon‐like peptide‐1, glucose‐dependent insulinotropic polypepide, and dipeptidyl peptidase‐4 inhibitors in experimental animals , 2016, Journal of diabetes investigation.
[3] N. Marx,et al. Interleukin-6 predicts inflammation-induced increase of Glucagon-like peptide-1 in humans in response to cardiac surgery with association to parameters of glucose metabolism , 2016, Cardiovascular Diabetology.
[4] P. Preshaw,et al. Detection and diagnosis of periodontal conditions amenable to prevention , 2015, BMC Oral Health.
[5] A. Åstrøm,et al. Influence of type 2 diabetes on local production of inflammatory molecules in adults with and without chronic periodontitis: a cross-sectional study , 2015, BMC oral health.
[6] B. Mealey,et al. American Academy of Periodontology Task Force Report on the Update to the 1999 Classification of Periodontal Diseases and Conditions. , 2015, Journal of periodontology.
[7] B. Heitmann,et al. The Association Between Periodontal Disease and Overweight and Obesity : A Systematic Review , 2015 .
[8] A. Pfeiffer,et al. GIP increases adipose tissue expression and blood levels of MCP-1 in humans and links high energy diets to inflammation: a randomised trial , 2015, Diabetologia.
[9] A. Åstrøm,et al. Impact of Chronic Periodontitis on Levels of Glucoregulatory Biomarkers in Gingival Crevicular Fluid of Adults with and without Type 2 Diabetes , 2015, PloS one.
[10] F. Tacke,et al. GLP-1 Secretion Is Increased by Inflammatory Stimuli in an IL-6–Dependent Manner, Leading to Hyperinsulinemia and Blood Glucose Lowering , 2014, Diabetes.
[11] D. Drucker,et al. Lipopolysaccharides-Mediated Increase in Glucose-Stimulated Insulin Secretion: Involvement of the GLP-1 Pathway , 2014, Diabetes.
[12] S. Khalili,et al. Tumor Necrosis Factor-α and Interleukin-6: Potential Interorgan Inflammatory Mediators Contributing to Destructive Periodontal Disease in Obesity or Metabolic Syndrome , 2013, Mediators of inflammation.
[13] J. Holst,et al. Glucose-Dependent Insulinotropic Polypeptide , 2011, Diabetes.
[14] J. Holst,et al. Glucose-Dependent Insulinotropic Polypeptide A Bifunctional Glucose-Dependent Regulator of Glucagon and Insulin Secretion in Humans , 2011 .
[15] M. Gabriele,et al. Systemic inflammation following non-surgical and surgical periodontal therapy. , 2010, Journal of clinical periodontology.
[16] J. Ruidavets,et al. Metabolic syndrome, insulin resistance, and periodontitis: a cross-sectional study in a middle-aged French population. , 2010, Journal of clinical periodontology.
[17] P. Halban,et al. Interleukin-6 regulates pancreatic α-cell mass expansion , 2008, Proceedings of the National Academy of Sciences.
[18] A. Golay,et al. Association of fasting glucagon and proinsulin concentrations with insulin resistance , 2007, Diabetologia.
[19] N Claffey,et al. Advances in the progression of periodontitis and proposal of definitions of a periodontitis case and disease progression for use in risk factor research. Group C consensus report of the 5th European Workshop in Periodontology. , 2005, Journal of clinical periodontology.